L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind,,parallel-sequential trials

American Journal of Psychiatry

Volumn 169, Issue 12, 2012, Pages 1267-1274

  Papakostas, George I ^a   Shelton, Richard C ^a   Zajecka, John M ^a   Etemad, Bijan ^a   Rickels, Karl ^a   Clain, Alisabet ^a   Baer, Lee ^a   Dalton, Elizabeth D ^a   Sacco, Garret R ^a   Schoenfeld, David ^a   Pencina, Michael ^a   Meisner, Allison ^a   Bottiglieri, Teodoro ^a   Nelson, Erik ^a   Mischoulon, David ^a   Alpert, Jonathan E ^a   Barbee, James G ^a   Zisook, Sidney ^a   Fava, Maurizio ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FOLIC ACID DERIVATIVE; METHYLFOLATE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MENTAL DISEASE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 84871824309     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11071114     Document Type: Article

References (35)

1. Abou-Saleh MT, Coppen A: Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989; 80:78-82 (Pubitemid 19179480)
2. Carney MWP: Serum folate values in 423 psychiatric patients. BMJ 1967; 4:512-516
3. Reynolds EH, Preece JM, Bailey J, Coppen A: Folate deficiency in depressive illness. Br J Psychiatry 1970; 117:287-292
4. Edeh J, Toone BK: Antiepileptic therapy, folate deficiency, and psychiatric morbidity: a general practice survey. Epilepsia 1985; 26:434-440 (Pubitemid 16226442)
5. Shorvon SD, Carney MWF, Chanarin I, Reynolds EH: The neuropsychiatry of megaloblastic anemia. Br Med J 1980; 281:1036-1038
6. Ghadirian AM, Ananth J, Engelsmann F: Folic acid deficiency and depression. Psychosomatics 1980; 21:926-929 (Pubitemid 11169349)
7. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MWP, Toone BK, Reynolds EH: Folate deficiency, biopterin, and monoamine metabolism in depression. Psychol Med 1992; 22:871-876 (Pubitemid 23006998)
8. Wilkinson AM, Anderson DN, Abou-Saleh MT, Wesson M, Blair JA, Farrar G, Leeming RJ: 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. J Affect Disord 1994; 32:163-168 (Pubitemid 24341680)
9. Wesson VA, Levitt AJ, Joffe RT: Change in folate status with antidepressant treatment. Psychiatry Res 1994; 53:313-322 (Pubitemid 24320075)
10. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T: Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154:426-428 (Pubitemid 27098298)
11. Alpert M, Silva RR, Pouget ER: Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol 2003; 23:309-313 (Pubitemid 36807797)
12. Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M: Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004; 65:1090-1095
13. Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M: Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry 2004; 65:1096-1098
14. Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M: The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005; 8:523-528 (Pubitemid 41400882)
15. Papakostas GI, Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Alpert JE, Nierenberg AA, Fava M: Brain MRI white matter hyperintensities, cardiovascular risk factors, and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (part II). Psychiatry Res 2005; 140:301-307 (Pubitemid 41660974)
16. Coppen A, Chaudhry S, Swade C: Folic acid enhances lithium prophylaxis. J Affect Disord 1986; 10:9-13 (Pubitemid 16109820)
17. Coppen A, Bailey J: Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000; 60:121-130
18. Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M: Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002; 14:33-38 (Pubitemid 34538830)
19. Godfrey PSA, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH: Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336:392-395 (Pubitemid 20252436)
20. Passeri M, Ventura S, Abate G, Cucinotta D, LaGrec P: Oral 5-methyltetrahydrofolate (MTHF) in depression association with senile organic mental disorders (OMDs): a double-blind, multicenter study vs trazodone (TRZ). Aging (Milano) 1993; 5:63-71 (Pubitemid 23117911)
21. Guaraldi GP, Fava M, Mazzi F, la Greca P: An open trial of methyltetrahydrofolate in elderly depressed patients. Ann Clin Psychiatry 1993; 5:101-105 (Pubitemid 23210906)
22. Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M: S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol 2004; 24:661-664 (Pubitemid 39518665)
23. Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M: S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 2010; 167:942-948
24. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34:73-82 (Pubitemid 38139442)
25. Fava M, Evins AE, Dorer DJ, Schoenfeld DA: The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom 2003; 72:115-127 (Pubitemid 36469860)
26. First MB, Spitzer LR, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders With Psychotic Screen (SCID-I/P w/ Psychotic Screen) Version 2.0. New York, NY, Biometrics Research Department, 1995
27. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
28. Guy W, ed: ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 218-222
29. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57 289-300
30. Tamura RN, Huang X: An examination of the efficiency of the sequential parallel design in psychiatric clinical trials. Clin Trials 2007; 4:309-317 (Pubitemid 47572263)
31. Nelson JC, Papakostas GI: Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009; 166:980-991
32. Bauer M, Dopfmer S: Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999; 19:427-434 (Pubitemid 29451507)
33. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905-1917 (Pubitemid 44807782)
34. Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack MA: A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom 2012; 81:87-97
35. Chen YF, Yang Y, Hung HM, Wang SJ: Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials. Contemp Clin Trials 2011; 32:592-604